Jan. 28, 2023
A Surprisingly Oral CD73 Inhibitor from Calithera
compound 49
orally bioavailable CD73 inhibitor single agent, dose-dependent antitumor efficacy in mice opt. of known CD73 inhibitor J. Med. Chem., December 18, 2022 Calithera Biosciences, South San Fransisco, CA
Loading...
